McKesson (MCK) – Research Analysts’ Weekly Ratings Updates

McKesson (NYSE: MCK) has recently received a number of price target changes and ratings updates:

• 5/18/2026 – McKesson was downgraded by Weiss Ratings from “buy (b+)” to “buy (b)”.
• 5/14/2026 – McKesson had its price target lowered by Citigroup Inc. from $975.00 to $945.00. They now have a “buy” rating on the stock.
• 5/12/2026 – McKesson had its price target lowered by Wells Fargo & Company from $925.00 to $812.00. They now have an “equal weight” rating on the stock.
• 5/8/2026 – McKesson had its price target raised by UBS Group AG from $1,000.00 to $1,050.00. They now have a “buy” rating on the stock.
• 5/8/2026 – McKesson had its “buy” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $875.00 price target on the stock.
• 5/8/2026 – McKesson had its price target lowered by JPMorgan Chase & Co. from $1,107.00 to $1,015.00. They now have an “overweight” rating on the stock.
• 5/4/2026 – McKesson had its “buy (b+)” rating reaffirmed by Weiss Ratings.
• 5/2/2026 – McKesson was upgraded by Wall Street Zen from “hold” to “buy”.
• 4/28/2026 – McKesson is now covered by William Blair. They set an “outperform” rating on the stock.
• 4/22/2026 – McKesson had its price target lowered by UBS Group AG from $1,012.00 to $1,000.00. They now have a “buy” rating on the stock.
• 4/11/2026 – McKesson was downgraded by Wall Street Zen from “buy” to “hold”.
• 4/6/2026 – McKesson had its price target lowered by Bank of America Corporation from $1,040.00 to $1,000.00. They now have a “buy” rating on the stock.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be issued a dividend of $0.82 per share. The ex-dividend date is Monday, June 1st. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is currently 8.53%.

Insider Activity

In other news, EVP Michele Lau sold 2,725 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the sale, the executive vice president owned 3,247 shares in the company, valued at $3,214,530. This trade represents a 45.63% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.08% of the stock is owned by corporate insiders.

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.